AXOGEN INC. - COMMON STOCK

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

14 Mar 2023 07:00:01 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel

06 Mar 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. to report fourth quarter 2022 financial results and host conference call on March 14, 2023

02 Mar 2023 16:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer

13 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

09 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

05 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

04 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

19 Dec 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Third Quarter Financial Results

08 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

03 Nov 2022 16:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.

31 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022

20 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand

22 Sep 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 Second Quarter Financial Results

03 Aug 2022 16:01:01 By Nasdaq GlobeNewswire

Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference

29 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Announces Organizational Updates, Preliminary Second Quarter Revenue and Reaffirms Full-Year 2022 Financial Guidance

18 Jul 2022 16:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints William Burke to Board of Directors

11 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. to present at the Jefferies Virtual Healthcare Conference and the JMP Securities Life Sciences Conference

18 May 2022 07:00:00 By Nasdaq GlobeNewswire

Axogen, Inc Reports 2022 First Quarter Financial Results

04 May 2022 16:05:01 By Nasdaq GlobeNewswire

Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft

04 May 2022 16:01:00 By Nasdaq GlobeNewswire